Cargando…
Down-regulation of LATS kinases alters p53 to promote cell migration
p53 is a pivotal tumor suppressor and a major barrier against cancer. We now report that silencing of the Hippo pathway tumor suppressors LATS1 and LATS2 in nontransformed mammary epithelial cells reduces p53 phosphorylation and increases its association with the p52 NF-κB subunit. Moreover, it part...
Autores principales: | Furth, Noa, Bossel Ben-Moshe, Noa, Pozniak, Yair, Porat, Ziv, Geiger, Tamar, Domany, Eytan, Aylon, Yael, Oren, Moshe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691886/ https://www.ncbi.nlm.nih.gov/pubmed/26588988 http://dx.doi.org/10.1101/gad.268185.115 |
Ejemplares similares
-
LATS1 and LATS2 suppress breast cancer progression by maintaining cell identity and metabolic state
por: Furth, Noa, et al.
Publicado: (2018) -
Transcriptional profiling reveals a subset of human breast tumors that retain wt TP53 but display mutant p53‐associated features
por: Benor, Gal, et al.
Publicado: (2020) -
Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation
por: Aylon, Yael, et al.
Publicado: (2009) -
Context-specific microRNA analysis: identification of functional microRNAs and their mRNA targets
por: Bossel Ben-Moshe, Noa, et al.
Publicado: (2012) -
The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation
por: Aylon, Yael, et al.
Publicado: (2016)